Internal Medicine, Rheumatology · Pueblo, CO
NPI
1760799894
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1619 N. Greenwood, Suite 200
Pueblo, CO, 81003
Phone (719) 562-2030
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,970 services
Medicare patients, 2024
273
Average age 71
Drug cost, 2024
$8.7M
6,320 prescriptions
Company payments, 2025
$159
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rupal Chavda was code 99214 (office e&m - established), 341 times for 221 patients. In total Rupal Chavda billed 1,970 services in 22 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 341 | 221 | $92.14 | $31K |
| 99204 Office E&M - New | Office | 41 | 41 | $126.75 | $5,197 |
| 99443 Telephone Services | Office | 37 | 32 | $74.39 | $2,752 |
| 99215 Office E&M - Established | Office | 19 | 17 | $144.65 | $2,748 |
| 96372 Injection Administration | Office | 17 | 13 | $10.23 | $174 |
| 99441 Telephone Services | Office | 16 | 15 | $37.03 | $592 |
| 99205 Office E&M - New | Office | 11 | 11 | $165.67 | $1,822 |
By year: 2022 $60K for 1,204 services; 2023 $58K for 904 services; 2024 $60K for 1,970 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rupal Chavda prescribed most often to Medicare patients was Prednisone, with 914 prescriptions and refills. In total Rupal Chavda wrote 6,320 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 914 | 1,433 | 309 | $5,326 |
| Hydroxychloroquine Sulfate Generic | 665 | 1,755 | 202 | $35K |
| Methotrexate Methotrexate Sodium | 662 | 1,569 | 184 | $18K |
| Duloxetine Hcl Generic | 425 | 1,115 | 154 | $12K |
| Humira(Cf) Pen Adalimumab | 229 | 245 | 30 | $1.8M |
| Cyclobenzaprine Hcl Generic | 205 | 277 | 74 | $1,894 |
| Leflunomide Generic | 181 | 438 | 63 | $10K |
| Xeljanz Xr Tofacitinib Citrate | 159 | 161 | 20 | $952K |
| Gabapentin Generic | 154 | 420 | 66 | $6,309 |
| Rinvoq Upadacitinib | 150 | 161 | 20 | $1.1M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 135 | 135 | 37 | $2,393 |
| Celecoxib Generic | 132 | 277 | 42 | $4,699 |
| Tramadol Hcl Generic | 131 | 133 | 42 | $757 |
| Folic Acid Generic | 120 | 352 | 46 | $1,364 |
| Orencia Clickject Abatacept | 116 | 147 | 21 | $886K |
Brand drugs: - claims; generic drugs: 4,949 claims; opioid claims: 268.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rupal Chavda $159 ($159 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $92.5.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.